Cybin is listed on the NASDAQ stock exchange, receiving buy rating coverage from TD Cowen, while Millennium Management increased its stake.

The entities involved

• Cybin →

  Canadian pharmaceutical company

  Nothing else this week.

• Nasdaq →

  American fully electronic stock exchange

  • MillerKnoll shares traded on Nasdaq and Benchmark upgraded its stock rating on October 31, 2026.20:36
  • AXT Inc. is listed on the Nasdaq exchange, files required disclosures with the SEC, and Jesse Chen serves as a Director.19:42
• TD Cowen →

  American investment bank

  • TD Cowen analysts are scrutinizing the business strategies of major financial institutions, including U.S. Bancorp and Wells Fargo, while Morgan Stanley also contributes to the inquiry.19:44
  • Multiple financial firms, including Morgan Stanley and TD Cowen, updated price targets and ratings for various institutions on October 31, 2026.19:44

Related events

• TD Cowen reiterated a buy rating on MBX Biosciences shares, and Citigroup restated an outperform rating on the company.Jun 29
• Analyst rating updates for Krystal Biotech, including a buy rating from TD Cowen and a consensus rating from MarketBeat.Jul 14
• Analyst firms Jefferies, TD Cowen, and Raymond James Financial provided rating updates for Black Diamond Therapeutics, alongside MarketBeat consensus data.Sun 07:42
• Multiple financial firms, including TD Cowen, Goldman Sachs, and Mizuho, issued various rating changes and price target updates across several stocks.Oct 19
• Truist Financial started coverage on Genmab shares, and TD Cowen raised rating and price target for the company, which trades on Nasdaq.Sep 9